Nautilus Biotechnology, Inc.
NAUT· Nasdaq
NAUTNautilus Biotechnology, Inc.
Filed Mar 30, 2021 · 10-K · 89 days after period end · 0001140361-21-010864
derived · Computed from the longer spans the company filed.
no prior Q4 2019 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2020 · filed Mar 30, 2021 · 89 d after period end
Nautilus Biotechnology, Inc. · CIK 1808805 · Engraved from SEC EDGAR
